RIGA, Latvia–(BUSINESS WIRE)–May 30, 2008–News Corporation
today announced it has completed the acquisition of a 30% stake in TV
Riga, a Latvian Russian language free-to-air broadcaster, increasing
its ownership to 100%.
The transaction represents a consolidation of News Corporation
European Television’s (NCE TV) assets in Latvia, which now include
100% ownership of LNT, the leading Latvian entertainment […]
Pramerica Names George Passaris to Lead Alternatives Product
Management in Europe
FRAMINGHAM, Mass.–(BUSINESS WIRE)–May 22, 2008–Staples, Inc.
(Nasdaq: SPLS) and its wholly owned subsidiary, Staples Acquisition
B.V., today announced that Staples Acquisition B.V. has commenced a
cash tender offer to purchase all of Corporate Express U.S. Finance
Inc.’s (formerly known as Buhrmann U.S. Inc.) outstanding 8.25 percent
Senior Subordinated Notes due July 1, 2014 (the “2014 Notes”) and
7.875 percent Senior Subordinated […]
New Facility Will Serve Automotive Coatings, Industrial Coatings Customers
FRAMINGHAM, Mass.–(BUSINESS WIRE)–May 21, 2008–In light of
today’s news about the proposed Corporate Express N.V. acquisition of
Lyreco SAS, Staples, Inc.(Nasdaq: SPLS) and Staples Acquisition B.V.
are considering all options.
Staples Acquisition reaffirms that its all cash offer of EUR 8.00
per ordinary share delivers certain, immediate and superior value to
Corporate Express shareholders. Staples Acquisition’s offer does so
without the substantial […]
Jurisdictional capabilities established in Amsterdam
— Compelling all cash offer of EUR 8.00 per ordinary share,
representing a premium of approximately 90 percent to
Corporate Express’ unaffected share price
— Attractive all cash offer of EUR 3.15 per share for the
preference shares A
— Attractive all cash offer of EUR 1,164.72 per bond for the
convertible bonds
— Offer expires at 17.30 hours CET (11.30 hours EDT) on Friday,
27 June 2008
LOS ANGELES–(BUSINESS WIRE)–May 15, 2008–Response Genetics,
Inc. (NASDAQ: RGDX), a company focused on the development and
commercialization of molecular diagnostic tests for cancer, today
announced its consolidated financial results for the three months
ended March 31, 2008.
“These results, coupled with our expansion of the ResponseDX:
Lung(TM) and ResponseDX: Colon(TM) test offerings illustrate the
company’s commitment to meeting the operational goals we […]
LOS ANGELES–(BUSINESS WIRE)–May 13, 2008–Response Genetics,
Inc. (NASDAQ: RGDX) will announce first quarter 2008 financial results
in a press release Thursday, May 15 after close of market.
Response Genetics, Inc. also announced today that Kathleen
Danenberg, President and CEO of Response Genetics, Inc., will present
at the Rodman & Renshaw Fifth Annual Global Healthcare Conference at
5:15 p.m. CET / 11:15 […]
— RESTORE 2 Shows Efficacy in Both 600 mg and 900 mg Doses,
Building upon Prior Positive Phase III Results with 1200 mg
Dose
— Retigabine is a Potentially Significant Advance for Treatment
of Epilepsy
— Valeant Plans to Submit NDA & MAA before End of 2008
Conference Call Scheduled for Today at 1:00 p.m. EDT (10:00 a.m.
PDT)